House Bills - 110th Congress

H. R. 2900—The Food and Drug Administration Amendments Act of 2007

On June 28, 2007, Representative John Dingell (D-MI) introduced H.R. 2900, the Food and Drug Administration Amendments Act of 2007.    The bill is focused primarily on FDA and contains sections regarding user fees and drug safety monitoring procedures. The bill also contains a number of provisions of interest to NIH. Specifically, the bill would (1) expand the current ClinicalTrials.gov registry to include mandatory reporting of most drug and device clinical trials, (2) require sponsors of clinical trials to also report results of those trials to NIH, (3) reauthorize the Best Pharmaceuticals for Children Act, and (4) expand pediatric medical device research.   The bill was referred to the House Committee on Energy and Commerce.

COMMITTEE/SUBCOMMITTEE ACTION

July 11, 2007 – The House Committee on Energy and Commerce reported H.R. 2900.

Legislative Update (May 2008): The Food and Drug Administration Amendments Act of 2007